Successful treatment of super-refractory tonic status epilepticus with rufinamide: first clinical report

Rufinamide (RUF) is a novel antiepileptic agent that has entered clinical use within the last 10 years, thought to act through modulation of sodium channel activity[1].

Source: Seizure: European Journal of Epilepsy - April 18, 2016 Category: Neurology Authors: A.G.B. Thompson, H.R. Cock Tags: Clinical letter Source Type: research